Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Improvement in Gastrointestinal Health: BPC-157, with its origins in gastric juice, has demonstrated significant potential in combating and possibly preventing gastrointestinal disorders, including inflammatory bowel disease, Crohns disease, and symptoms of leaky gut
Because TB-500 distributes systemically regardless of injection site, there is no requirement to inject near the injury
KLOW is a supplier designation for a pre-blended four-component research vial, not a single chemical entity
This solution is intended for controlled research environments requiring low-concentration acetic acid in a sterile, injectable-grade format
US$ 28.01
US$ 27.75
US$ 26.67
US$ 24.20
US$ 26.27
US$ 25.52
US$ 26.78
